Methadone maintenance treatment has been used for over 50 years to bring life back to those suffering from addiction to opioids such as heroin, oxycontin, hydromorphone, fentanyl, morphine, opium, etc.

Methadone is a long-term treatment for individuals with opioid use disorder. It involves the regular, supervised administration of methadone, to reduce cravings and withdrawal symptoms associated with opioid dependence.

Unlike short-acting opioids like fentanyl, methadone provides a stable level of medication in the bloodstream, preventing the highs and lows of opioid use and helping patients regain stability in their lives.

Methadone allows individuals to manage their addiction by reducing illicit opioid use, lowering the risk of overdose, and improving overall quality of life. It also enables patients to focus on other aspects of recovery.

Methadone is taken orally, usually once daily, under the supervision of a healthcare provider to ensure compliance and minimize misuse.

The goal of MMT is to stabilize the patient’s condition and, over time, potentially taper off methadone, though many patients may remain on maintenance for an extended period to prevent relapse.

Suboxone maintenance treatment has been used for several decades to bring life back to those suffering from addiction to opioids such as heroin, oxycontin, hydromorphone, fentanyl, morphine, opium, etc.

Suboxone is generally is a long-term treatment approach for individuals with opioid use disorder. It involves the regular, supervised administration of suboxone to reduce cravings and withdrawal symptoms.

Unlike short-acting opioids like fentanyl, suboxone provides a stable level of medication in the bloodstream, preventing the highs and lows of opioid use and helping patients regain stability in their lives.

Suboxone programs allow individuals to manage their addiction by reducing illicit opioid use, lowering the risk of overdose, and improving overall quality of life.

It also enables patients to focus on other aspects of recovery, such as mental health care, employment, and rebuilding relationships. suboxone is taken, under the supervision of a physician to ensure compliance and minimize misuse.

The goal of the suboxone program is to stabilize the patient’s condition and, over time, potentially taper off suboxone, though many patients may remain on maintenance for an extended period to prevent relapse.

Slow-release oral morphine (SROM) is an option for patients with severe opioid use disorder (OUD).

Morphine is particularly an option when suboxone and methadone have been ineffective, are not appropriate, are not enough, or have been refused.

Clinical recommendations suggest considering slow-release morphine (kadian) for adults with moderate-severe addiction to opioids such as fentanyl in certain circumstances.

Slow-release morphine (kadian) appears to be comparable to methadone as an opioid agonist therapy for patients with opioid addiction.

With morphine, opioid-addicted patients report reduced cravings, few side effects, and elevated mood, as well as some evidence of improved function.

The goal of morphine dosing is to find a dose that manages withdrawal symptoms and cravings without causing sedation or adverse effects.

Stress or Psychogenic weight gain refers to weight gain driven primarily by psychological factors rather than physical or metabolic causes. This phenomenon often arises from emotional and mental health challenges such as stress, anxiety, depression, and emotional eating.

When individuals experience these psychological states, they may turn to food for comfort, leading to increased caloric intake, especially of high-sugar, high-fat, and high-calorie foods.

Individuals experiencing psychogenic weight gain may engage in frequent episodes of emotional eating, where food consumption becomes a coping mechanism for stress, anxiety, or depression.

Additionally, psychogenic weight gain can be accompanied by feelings of guilt or shame related to eating habits, further perpetuating the cycle of emotional eating and weight gain.

Managing psychogenic weight gain involves a multifaceted approach: psychotherapy, diet change, exercise and medications. Medications that can help treat psychogenic weight gain are often focused on addressing the underlying psychological factors contributing to the weight gain.

Weight loss medications like orlistat or like semaglutide (Ozempic or Wegovy) may be considered in some cases. Medications used to treat Binge Eating Disorder (BED) include lisdexamfetamine (Vyvanse) can also help.

Cocaine addiction is a chronic, relapsing condition characterized by compulsive drug-seeking behavior despite harmful consequences.

Treatment can include medications such as lisdexamfetamine, guanfacine , wellbutrin, and modafinil.

Switching from subxone to methadone is less cumbersome than the opposite. In most cases, suboxone can be stopped with methadone starting the next day at the usual starting dose of methadone.

Treatment can include medications such as lisdexamfetamine (Vyvanse), and selective serotonin reuptake inhibitors (SSRIs) like fluoxetine (Prozac), sertraline (Zoloft).

Treatment can include medications such as lisdexamfetamine (Vyvanse), and selective serotonin reuptake inhibitors (SSRIs) like fluoxetine (Prozac), sertraline (Zoloft).